Consequently, the combination of IHCH9033 with FLT3i quizartinib demonstrated significant synergistic cytotoxic effects in the FLT3-ITD AML cell lines MV-4-11 and MOLM-13 (Fig. 4a). Here, FLT3 is linked to acute myeloid leukemia.